Načítá se...
Common carotid artery rupture during treatment with lenvatinib for anaplastic thyroid cancer
Anaplastic thyroid cancer is a fatal disease for which no effective therapeutic strategies exist. Lenvatinib, a tyrosine-kinase inhibitor that targets vascular endothelial growth factor receptor, has recently been approved in Japan for the treatment of patients with unresectable thyroid cancer inclu...
Uloženo v:
| Vydáno v: | Int Cancer Conf J |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Japan
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498322/ https://ncbi.nlm.nih.gov/pubmed/31149454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-016-0257-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|